• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Delta 放射组学分析预测接受新辅助化疗的局部晚期宫颈癌患者的中高危因素。

Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.

机构信息

Department of Radiation Oncology, Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

School of Nuclear Science and Technology, University of South China, Hengyang, China.

出版信息

Sci Rep. 2023 Nov 8;13(1):19409. doi: 10.1038/s41598-023-46621-y.

DOI:10.1038/s41598-023-46621-y
PMID:37938596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10632513/
Abstract

This study aimed to assess the feasibility of using magnetic resonance imaging (MRI)-based Delta radiomics characteristics extrapolated from the Ax LAVA + C series to identify intermediary- and high-risk factors in patients with cervical cancer undergoing surgery following neoadjuvant chemoradiotherapy. A total of 157 patients were divided into two groups: those without any intermediary- or high-risk factors and those with one intermediary-risk factor (negative group; n = 75). Those with any high-risk factor or more than one intermediary-risk factor (positive group; n = 82). Radiomics characteristics were extracted using Ax-LAVA + C MRI sequences. The data was divided into training (n = 126) and test (n = 31) sets in an 8:2 ratio. The training set data features were selected using the Mann-Whitney U test and the Least Absolute Shrinkage and Selection Operator (LASSO) test. The best radiomics features were then analyzed to build a preoperative predictive radiomics model for predicting intermediary- and high-risk factors in cervical cancer. Three models-the clinical model, the radiomics model, and the combined clinic and radiomics model-were developed in this study utilizing the random forest Algorithm. The receiver operating characteristic (ROC) curve, decision curve analysis (DCA), accuracy, sensitivity, and specificity were used to assess the predictive efficacy and clinical benefits of each model. Three models were developed in this study to predict intermediary- and high-risk variables associated with postoperative pathology for patients who underwent surgery after receiving neoadjuvant radiation. In the training and test sets, the AUC values assessed using the clinical model, radiomics model, and combined clinical and radiomics models were 0.76 and 0.70, 0.88 and 0.86, and 0.91 and 0.89, respectively. The use of machine learning algorithms to analyze Delta Ax LAVA + C MRI radiomics features can aid in the prediction of intermediary- and high-risk factors in patients with cervical cancer receiving neoadjuvant therapy.

摘要

本研究旨在评估基于磁共振成像(MRI)的 Delta 放射组学特征从 Ax LAVA+C 系列中提取出来,以识别接受新辅助放化疗后手术的宫颈癌患者中中高危因素的可行性。总共 157 名患者被分为两组:无中高危因素组(n=75)和有一个中危因素的组(阴性组)。有任何高危因素或一个以上中危因素的组(阳性组,n=82)。使用 Ax-LAVA+C MRI 序列提取放射组学特征。数据按 8:2 的比例分为训练集(n=126)和测试集(n=31)。使用 Mann-Whitney U 检验和最小绝对收缩和选择算子(LASSO)检验选择训练集数据特征。然后分析最佳放射组学特征,以建立术前预测放射组学模型,预测宫颈癌中高危因素。本研究利用随机森林算法建立了三种模型——临床模型、放射组学模型和联合临床放射组学模型。利用受试者工作特征(ROC)曲线、决策曲线分析(DCA)、准确性、敏感性和特异性评估了每个模型的预测效果和临床获益。本研究建立了三种模型,以预测接受新辅助放疗后接受手术的患者术后病理相关的中高危变量。在训练集和测试集中,临床模型、放射组学模型和联合临床放射组学模型评估的 AUC 值分别为 0.76 和 0.70、0.88 和 0.86、0.91 和 0.89。使用机器学习算法分析 Delta Ax LAVA+C MRI 放射组学特征有助于预测接受新辅助治疗的宫颈癌患者的中高危因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/51092630668a/41598_2023_46621_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/ff857dba46bb/41598_2023_46621_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/53c75b857ed2/41598_2023_46621_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/c91a8d8ed66f/41598_2023_46621_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/51092630668a/41598_2023_46621_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/ff857dba46bb/41598_2023_46621_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/53c75b857ed2/41598_2023_46621_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/c91a8d8ed66f/41598_2023_46621_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bc1/10632513/51092630668a/41598_2023_46621_Fig4_HTML.jpg

相似文献

1
Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.基于 Delta 放射组学分析预测接受新辅助化疗的局部晚期宫颈癌患者的中高危因素。
Sci Rep. 2023 Nov 8;13(1):19409. doi: 10.1038/s41598-023-46621-y.
2
Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer.基于术前MRI的影像组学分析预测局部晚期宫颈癌患者新辅助化疗后淋巴结转移
Front Oncol. 2024 May 8;14:1376640. doi: 10.3389/fonc.2024.1376640. eCollection 2024.
3
[A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].[基于MRI影像组学的局部晚期直肠癌患者在PD-1抗体联合全新辅助放化疗后病理完全缓解的预测模型]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Mar 25;25(3):228-234. doi: 10.3760/cma.j.cn441530-20211222-00527.
4
MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.基于 MRI 的 delta 放射组学可预测局部晚期直肠癌新辅助放化疗后的病理完全缓解。
Acad Radiol. 2021 Nov;28 Suppl 1:S95-S104. doi: 10.1016/j.acra.2020.10.026. Epub 2020 Nov 12.
5
Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.基于动态对比增强 MRI 的放射组学预测新辅助治疗乳腺癌患者病理完全缓解的价值。
Acad Radiol. 2023 Aug;30(8):1638-1647. doi: 10.1016/j.acra.2022.11.006. Epub 2022 Dec 21.
6
Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.多参数 MRI 的放射组学分析预测局部晚期直肠癌新辅助放化疗的病理完全缓解。
Eur Radiol. 2019 Mar;29(3):1211-1220. doi: 10.1007/s00330-018-5683-9. Epub 2018 Aug 20.
7
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.基于放射组学的局部晚期宫颈癌患者接受新辅助放化疗后两年临床结局的预测。
Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24.
8
Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.基于计算机断层扫描的影像组学模型预测甲状腺乳头状癌中央颈部淋巴结转移:一项多中心研究。
Front Endocrinol (Lausanne). 2021 Oct 21;12:741698. doi: 10.3389/fendo.2021.741698. eCollection 2021.
9
Prediction of recurrence of ischemic stroke within 1 year of discharge based on machine learning MRI radiomics.基于机器学习MRI影像组学对缺血性卒中出院后1年内复发的预测
Front Neurosci. 2023 May 4;17:1110579. doi: 10.3389/fnins.2023.1110579. eCollection 2023.
10
Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.基于 MRI 的放射组学模型评估直肠癌新辅助放化疗的治疗反应。
BMC Med Imaging. 2021 Feb 16;21(1):30. doi: 10.1186/s12880-021-00560-0.

引用本文的文献

1
Critical review of patient outcome study in head and neck cancer radiotherapy.头颈部癌放疗患者结局研究的批判性综述
Meta Radiol. 2025 Sep;3(3). doi: 10.1016/j.metrad.2025.100151. Epub 2025 Jul 29.
2
Artificial intelligence radiomics in the diagnosis, treatment, and prognosis of gynecological cancer: a literature review.人工智能影像组学在妇科癌症诊断、治疗及预后中的应用:文献综述
Transl Cancer Res. 2025 Apr 30;14(4):2508-2532. doi: 10.21037/tcr-2025-618. Epub 2025 Apr 27.
3
Delta-radiomics analysis based on magnetic resonance imaging to identify radiation proctitis in patients with cervical cancer after radiotherapy.

本文引用的文献

1
Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.由于缺乏放疗设备,采用新辅助化疗后行根治性手术治疗 FIGO 2018 期 IB3/IIA2 宫颈癌的临床结局:与同期放化疗的回顾性比较。
PLoS One. 2022 Mar 24;17(3):e0266001. doi: 10.1371/journal.pone.0266001. eCollection 2022.
2
Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future.宫颈癌新辅助化疗后手术治疗:过去、现在与未来
Int J Gynecol Cancer. 2022 Mar;32(3):260-265. doi: 10.1136/ijgc-2021-002531.
3
基于磁共振成像的Delta放射组学分析用于识别宫颈癌放疗后患者的放射性直肠炎。
Front Oncol. 2025 Jan 29;15:1523567. doi: 10.3389/fonc.2025.1523567. eCollection 2025.
4
MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.局部晚期宫颈癌放化疗期间用于预后评估的MRI影像组学变化分析
BMC Cancer. 2025 Jan 22;25(1):122. doi: 10.1186/s12885-025-13509-1.
5
Developing a novel dosiomics model to predict treatment failures following lung stereotactic body radiation therapy.开发一种新型剂量组学模型以预测肺立体定向体部放射治疗后的治疗失败情况。
Front Oncol. 2024 Dec 12;14:1438861. doi: 10.3389/fonc.2024.1438861. eCollection 2024.
6
Systemic immune-related spleen radiomics predict progression-free survival in patients with locally advanced cervical cancer underwent definitive chemoradiotherapy.全身免疫相关脾脏放射组学预测行根治性放化疗的局部晚期宫颈癌患者的无进展生存期。
BMC Med Imaging. 2024 Nov 15;24(1):310. doi: 10.1186/s12880-024-01492-1.
7
Predicting Bone Marrow Metastasis in Neuroblastoma: An Explainable Machine Learning Approach Using Contrast-Enhanced Computed Tomography Radiomics Features.基于增强 CT 影像组学特征的可解释机器学习方法预测神经母细胞瘤骨髓转移
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241290386. doi: 10.1177/15330338241290386.
8
Prediction of High-Risk Gastrointestinal Stromal Tumor Recurrence Based on Delta-CT Radiomics Modeling: A 3-Year Follow-up Study After Surgery.基于Delta-CT影像组学模型预测高危胃肠道间质瘤复发:术后3年随访研究
Clin Med Insights Oncol. 2024 Apr 15;18:11795549241245698. doi: 10.1177/11795549241245698. eCollection 2024.
MRI-based radiomics analysis improves preoperative diagnostic performance for the depth of stromal invasion in patients with early stage cervical cancer.
基于磁共振成像(MRI)的影像组学分析可提高早期宫颈癌患者基质浸润深度的术前诊断性能。
Insights Imaging. 2022 Jan 29;13(1):17. doi: 10.1186/s13244-022-01156-0.
4
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.Delta 放射组学预测肝转移结直肠癌患者对一线奥沙利铂化疗的反应
Cancers (Basel). 2022 Jan 4;14(1):241. doi: 10.3390/cancers14010241.
5
Predicting Tumor Budding Status in Cervical Cancer Using MRI Radiomics: Linking Imaging Biomarkers to Histologic Characteristics.利用MRI放射组学预测宫颈癌中的肿瘤芽生状态:将影像生物标志物与组织学特征相联系
Cancers (Basel). 2021 Oct 14;13(20):5140. doi: 10.3390/cancers13205140.
6
Structural and functional radiomics for lung cancer.肺癌的结构和功能放射组学。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3961-3974. doi: 10.1007/s00259-021-05242-1. Epub 2021 Mar 11.
7
Optimal treatment in locally advanced cervical cancer.局部晚期宫颈癌的最佳治疗方法。
Expert Rev Anticancer Ther. 2021 Jun;21(6):657-671. doi: 10.1080/14737140.2021.1879646. Epub 2021 Mar 11.
8
Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients.开发一种基于影像组学的新型CT图像标志物,用于检测宫颈癌患者的淋巴结转移。
Comput Methods Programs Biomed. 2020 Dec;197:105759. doi: 10.1016/j.cmpb.2020.105759. Epub 2020 Sep 16.
9
Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.ⅡB 期宫颈癌新辅助化疗后根治性手术与同期放化疗的比较:CSEM006 研究。
Int J Gynecol Cancer. 2021 Jan;31(1):129-133. doi: 10.1136/ijgc-2020-001357. Epub 2020 Jun 9.
10
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.NCCN 指南解读:宫颈癌,第 1.2020 版。
J Natl Compr Canc Netw. 2020 Jun;18(6):660-666. doi: 10.6004/jnccn.2020.0027.